Request Demo
Last update 18 Apr 2026
Anzurstobart
Last update 18 Apr 2026
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms Anti-SIRPα - Bristol Myers Squibb, BMS-986351, CC 95251 + [1] |
Target |
Action modulators |
Mechanism SIRPα modulators(Signal-regulatory protein alpha modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 524010623L
Source: *****
Sequence Code 1191632835H
Source: *****
Related
2
Clinical Trials associated with AnzurstobartNCT05168202
A Phase 1, Open-label, Dose Finding Study of CC-95251 Alone and in Combination With Antineoplastic Agents in Subjects With Acute Myeloid Leukemia and Myelodysplastic Syndromes
NCT03783403
A Phase 1, Open-label, Dose Finding Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, Alone and in Combination With Cetuximab or Rituximab in Subjects With Advanced Solid and Hematologic Cancers
100 Clinical Results associated with Anzurstobart
Login to view more data
100 Translational Medicine associated with Anzurstobart
Login to view more data
100 Patents (Medical) associated with Anzurstobart
Login to view more data
100 Deals associated with Anzurstobart
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myelodysplastic Syndromes | Phase 1 | United States | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Australia | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Canada | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | France | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Italy | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Norway | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Spain | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | Sweden | 19 Jan 2022 | |
| Myelodysplastic Syndromes | Phase 1 | United Kingdom | 19 Jan 2022 | |
| Relapsing acute myeloid leukemia | Phase 1 | United States | 19 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 56 | (Part A: Treatment 1) | lxudmlgsyl = kvipnrtajv bivcsvaxop (dtxvolkjtw, blhalgumnl - naheketcgz) View more | - | 25 Sep 2025 | ||
(Part A: Treatment 2) | lxudmlgsyl = zggvridzrd bivcsvaxop (dtxvolkjtw, bsjvkzgact - xtrmaskedg) View more | ||||||
NCT03783403 (EHA2022) Manual  | Phase 1 | Non-Hodgkin Lymphoma CD20 Positive | 17 | iuokpuizgc(mlsnqskacv) = frpruqfopr nlokqpxcnc (awzcdybmso ) View more | Positive | 12 May 2022 | |
Phase 1 | Non-Hodgkin's lymphoma refractory CD20 Positive | 18 | chciefqlfu(hkgjaujaqa) = NR gwkbctajiz (kjkjifcsfa ) View more | Positive | 05 Nov 2021 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free